Neuronetics, Inc.
STIM
$1.94
$0.2414.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 149.16M | 129.87M | 111.11M | 89.45M | 74.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.16M | 129.87M | 111.11M | 89.45M | 74.89M |
| Cost of Revenue | 76.45M | 63.78M | 48.12M | 32.04M | 20.13M |
| Gross Profit | 72.71M | 66.10M | 62.99M | 57.41M | 54.76M |
| SG&A Expenses | 97.16M | 92.67M | 89.06M | 83.49M | 75.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 180.19M | 167.14M | 148.78M | 127.57M | 108.86M |
| Operating Income | -31.04M | -37.27M | -37.67M | -38.12M | -33.97M |
| Income Before Tax | -39.14M | -44.61M | -48.55M | -48.54M | -43.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.14 | -44.61 | -48.55 | -48.54 | -43.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 137.00K | 108.00K | -248.00K | 33.00K | 19.00K |
| Net Income | -39.00M | -44.50M | -48.80M | -48.51M | -43.71M |
| EBIT | -31.04M | -37.27M | -37.67M | -38.12M | -33.97M |
| EBITDA | -27.63M | -34.21M | -34.99M | -35.79M | -31.98M |
| EPS Basic | -0.60 | -0.84 | -1.15 | -1.32 | -1.38 |
| Normalized Basic EPS | -0.37 | -0.51 | -0.62 | -0.72 | -0.76 |
| EPS Diluted | -0.60 | -0.84 | -1.15 | -1.32 | -1.38 |
| Normalized Diluted EPS | -0.37 | -0.51 | -0.62 | -0.72 | -0.76 |
| Average Basic Shares Outstanding | 263.71M | 231.63M | 194.59M | 158.46M | 126.46M |
| Average Diluted Shares Outstanding | 263.71M | 231.63M | 194.59M | 158.46M | 126.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |